Oxford BioTherapeutics' Private Equity Round

Oxford BioTherapeutics raised a round of funding on August 03, 2018. Investors include Calculus Capital.

Oxford BioTherapeutics is an international, clinical-stage biotechnology company focused on developing antibody-based therapies to treat cancer. Combining immuno-oncology, antibody-drug conjugates, an…

Articles about Oxford BioTherapeutics' Private Equity Round: